ASP1128

DRUG2 trials

Sponsors

Astellas Pharma Inc, Astellas Pharma Europe B.V.

Conditions

Acute Kidney Injury (AKI)Healthy Volunteers

Phase 1

A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects

CompletedNCT04742517

Astellas Pharma Europe B.V.Healthy Volunteers

Start: 2017-11-20End: 2018-09-07Updated: 2024-11-18

Phase 2

Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

CompletedNCT03941483

Astellas Pharma IncAcute Kidney Injury (AKI)

Start: 2019-11-01End: 2021-10-20Updated: 2024-12-04